Ever Fortune.AI Co., Ltd. (TPEX:6841)
Taiwan · Delayed Price · Currency is TWD 70.10
+0.60 (0.86%)
Dec 31, 2025, 2:31 PM CST
Ever Fortune.AI Revenue
Ever Fortune.AI had revenue of 72.95M TWD in the quarter ending September 30, 2025, a decrease of -14.70%. This brings the company's revenue in the last twelve months to 342.37M, up 23.31% year-over-year. In the year 2024, Ever Fortune.AI had annual revenue of 337.52M with 259.13% growth.
Revenue (ttm)
342.37M
Revenue Growth
+23.31%
P/S Ratio
19.34
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 337.52M | 243.54M | 259.13% |
| Dec 31, 2023 | 93.98M | 40.08M | 74.35% |
| Dec 31, 2022 | 53.90M | 15.66M | 40.94% |
| Dec 31, 2021 | 38.24M | 34.76M | 996.76% |
| Dec 31, 2020 | 3.49M | 2.29M | 190.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |